Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.35 |
| ▸ | SPR | P35270 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15312954 | 0.85 | CCR1 (0.42) | CCR1GAAKDM4ELMNAALDH1A1 | |
| SCHEMBL1775261 | 0.83 | POLB (0.46) | CCR1GAAKDM4ELMNAALDH1A1 | |
| SCHEMBL13523714 | 0.81 | GAA (0.50) | CCR1GAAKDM4ELMNAALDH1A1 | |
| SCHEMBL13045935 | 0.81 | GAA (0.44) | CCR1GAAKDM4ELMNAALDH1A1 | |
| SCHEMBL1774525 | 0.80 | GAA (0.43) | CCR1GAAKDM4EIRAK4POLB | |
| SCHEMBL2593635 | 0.79 | POLB (0.44) | CCR1GAAKDM4ELMNAALDH1A1 | |
| SCHEMBL1774312 | 0.78 | GAA (0.41) | CCR1GAAKDM4ELMNAPOLB | |
| SCHEMBL13169907 | 0.78 | GAA (0.46) | CCR1GAAKDM4ELMNAALDH1A1 | |
| SCHEMBL1228543 | 0.78 | CCR1 (0.48) | CCR1GAAALDH1A1SMN1; SMN2IRAK4 | |
| SCHEMBL1120082 | 0.77 | GAA (0.47) | CCR1GAAKDM4ELMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2563786-B1 | Ketoheteroarylpiperidine and piperazine derivatives as fungicides | BAYER IP GMBH (DE) | 2016-11-02 | — | — | EP | disclosed |
| US-9357779-B2 | Ketoheteroarylpiperdine and -piperazine derivatives as fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-06-07 | — | — | US | disclosed |
| US-9220266-B2 | Ketoheteroarylpiperidine and -piperazine derivatives as fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-12-29 | — | — | US | disclosed |
| US-20130274292-A1 | Ketoheteroarylpiperdine and -Piperazine Derivatives as Fungicides | BAYER CROPSCIENCE AG (DE) | 2013-10-17 | — | — | US | disclosed |
| EP-2563786-A1 | KETOHETEROARYLPIPERIDINE AND KETOHETEROARYLPIPERAZINE DERIVATES AS FUNGICIDES | Bayer CropScience AG (DE) | 2013-03-06 | — | — | EP | disclosed |
| US-20110312999-A1 | Ketoheteroarylpiperidine and -Piperazine Derivatives as Fungicides | BAYER CROPSCIENCE AG (DE) | 2011-12-22 | — | — | US | disclosed |
| WO-2011134969-A1 | KETOHETEROARYLPIPERIDINE AND KETOHETEROARYLPIPERAZINE DERIVATES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2011-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130274292-A1 | Ketoheteroarylpiperdine and -Piperazine Derivatives as Fungicides | CYP4Z1, CYP51A1, CYP1A1 | CCR1 939/4885GAA 234/4885KDM4E 95/4885 |
| US-20110312999-A1 | Ketoheteroarylpiperidine and -Piperazine Derivatives as Fungicides | CYP4Z1, CYP51A1, KCNH1 | CCR1 1075/4885GAA 209/4885KDM4E 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.